Pharmos Corporation

Basic Information

2 INNOVATION DR
Alachua, FL, 32615

Company Profile

n/a

Additional Details

Field Value
DUNS: n/a
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a


  1. PRODRUGS AND AQUEOUS FORMULATIONS OF DEXANABINOL

    Amount: $100,000.00

    N/A

    SBIR Phase I 1997 Department of Health and Human Services
  2. DEVELOPMENT OF A NONSURFACTANT FORMULATION FOR INDUCING AGENTS

    Amount: $318,778.00

    ADVERSE REACTIONS HAVE BEEN REPORTED TO OCCUR AFTER ADMINISTRATION OF COMPOUNDS SOLUBILIZED IN AQUEOUS VEHICLES. THESE SIDE EFFECTS MAY BE REDUCED OR ELIMINATED BY COMBINING THE PRIMARY INDUCING AGENT ...

    SBIR Phase II 1992 Department of Health and Human Services
  3. PARENTERAL FORMULATION FOR CARBAMAZEPINE

    Amount: $500,000.00

    THE FAVORABLE EFFICACY, TOXICITY AND ADVERSE SIDE-EFFECT PROFILES OF CARBAMAZEPINE (CBZ) CONTRIBUTE TO ITS WIDESPREADAND INCREASING USE TO CONTROL SEIZURES IN THE EPILETPTIC PATIENTS. HOWEVER, IN CASE ...

    SBIR Phase II 1992 Department of Health and Human Services
  4. PARENTERAL FORMULATION FOR CARBAMAZEPINE

    Amount: $49,941.00

    N/A

    SBIR Phase I 1991 Department of Health and Human Services
  5. IMPROVED THERAPY FOR DEPRESSION

    Amount: $50,000.00

    DEPRESSION IS A HETEROGENOUS DISEASE, COVERING A RANGE OF SEVERITY, QUALITIES, AND CAUSES THAT AFFECTS AN IMPORTANT PORTION OF POPULATION. NONE OF THE AVAILABLE TREATMENT MODALITIES OF DEPRESSION, INC ...

    SBIR Phase I 1990 Department of Health and Human Services
  6. DEVELOPMENT OF A NONSURFACTANT FORMULATION FOR INDUCING AGENTS

    Amount: $45,390.00

    N/A

    SBIR Phase I 1990 Department of Health and Human Services
  7. CROSS-AXIS COIL PLANET CENTRIFUGE CHROMATOGRAPH DESIGN AND SYNTHESIS OF BRAIN-SPECIFIC ANTIHERPETIC AGENTS

    Amount: $416,005.00

    A NEW COUNTERCURRENT CHROMATOGRAPHY INSTRUMENT, THE CROSS-AXIS FLOW-THROUGH COIL PLANET CENTRIFUGE IS PROPOSED FOR THE PREPARATIVE CHROMATOGRAPHY OF PEPTIDES. THIS IS AN APPARATUS THAT SEPARATES SUBST ...

    SBIR Phase II 1989 Department of Health and Human Services
  8. IMPROVED THERAPY FOR CNS TOXOPLASMOSIS

    Amount: $50,000.00

    CEREBRAL TOXOPLASMOSIS IS THE MOST COMMON OPPORTUNISTIC DISEASE AFFECTING THE BRAIN OF PATIENTS WITH ACQUIRED IMMUNEDEFICIENCY SYNDROME (AIDS). SULFONAMIDE TREATMENT IS INITIALLY EFFECTIVE IN TREATING ...

    SBIR Phase I 1989 Department of Health and Human Services
  9. IMPROVED DELIVERY OF ANTIVIRALS FOR CNS INFECTIONS

    Amount: $50,000.00

    HUMAN CYTOMEGALOVIRUS (HCMV) IS A COMMON AND NOT USUALLY SERIOUS INFECTIVE AGENT. HOWEVER, IN THE CASE OF ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS) AND OTHER IMMUNO-SUPPRESSEDSTATES, HCMV IS INORDINAT ...

    SBIR Phase I 1988 Department of Health and Human Services
  10. ORAL DELIVERY OF A SUSTAINED ESTRADIOL DELIVERY SYSTEM

    Amount: $462,000.00

    STUDIES ARE PROPOSED TO EVALUATE THE FEASIBILITY OF ORAL 17BETA-ESTRADIOL (E2) ADMINISTRATION USING A NOVEL REDOX SYSTEM. THIS CHEMICAL DELIVERY SYSTEM (CDS) IS BASED ON AN INTERCONVERSION OF A LIPOPH ...

    SBIR Phase II 1988 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government